Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Ipca Laboratories Limited
IPCALAB | NSE
1,649.40
INR7.50
0.46%
IPCALAB | NSE
Loading StockChartView...
About Ipca Laboratories Limited
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
08/06/2026
Close
1,649.40
Open
1,610.00
High
1,668.00
Low
1,610.00
Ipca Laboratories Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. It offers APIs in therapeutic areas of anti-hypertensive anti-malarial diuretic DMARD and anthelmintic. The company provides generic and branded formulations in the therapeutic segments including allergy anti-neoplastic/cancer drugs anti-arthritic anti-epileptic anti-hypertensive cardiology dermatology diabetology gastroenterology haematology neurology ophthalmology rheumatology and urology as well as respiratory psychiatry probiotics orthopedics oral anti diabetes drug nutraceuticals NSAIDs neuropathic pain malaria infectious diseases immunosuppressant hepatoprotectives helminthics fever and emollients/protectives. It exports its products to approximately 100 countries worldwide. The company was incorporated in 1949 and is based in Mumbai India.
View LessIPCALAB | NSE
Risk
34.5
Sharpe
0.24
Luna's Score
73/100
Recommendation
Buy
Luna says (IPCALAB | NSE)
What's Working
Positive Momentum
Strength based on increasing price with high volume
Low 6-Month Volatility (<30%)
High Current Volume and Positive 1-Day Return
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
What's not Working
High Short-term Volatility
Midcap (2B - 10B USD)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
36.0%1 month
34.5%3 months
27.2%6 months
26.3%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
72.46
Fwd. PE
-
Price to book
6.60
Debt to equity
0.23
Debt to assets
0.13
Ent. to EBITDA
30.35
Ent. to rev.
5.22
PEG
-
Other Fundamentals
EBITDA
13.42B
MarketCap
418.46B
MarketCap(USD)
4.37B
Div. yield
0.12
Op. margin
14.04
Erngs. growth
18.10
Rev. growth
31.80
Ret. on equity
7.67
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
198.00
Range1M
208.30
Range3M
264.30
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
2.25
Price X volume
1.53B
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 30.35 | 24.85 | Expensive |
| Ent. to Revenue | 5.22 | 11.40 | Cheaper |
| PE Ratio | 72.46 | 51.36 | Expensive |
| Price to Book | 6.60 | 6.83 | Par |
| Dividend Yield | 0.12 | 0.52 | Poor |
| Std. Deviation (3M) | 27.15 | 42.17 | Lower Risk |
| Debt to Equity | 0.23 | 0.35 | Cheaper |
| Debt to Assets | 0.13 | 0.17 | Cheaper |
| Market Cap | 418.46B | 290.82B | Market Leader |
